AST-004 (Astrocyte Pharmaceuticals)

N/A

Report date: 2025/06/27 14:45:05
NME

Base Information

Drug NameAST-004 (Astrocyte Pharmaceuticals)
Drug Alias NameAST-004
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdenosine A1 receptor agonistsAdenosine A3 receptor agonists
TargetsAdenosine A1 receptorAdenosine A3 receptor
Therapy Area/IndicationsStrokeBrain Injuries, Traumatic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesUT Health San Antonio
China Registration ClassN/A

Develop Information

Active CompaniesAstrocyte Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsStrokeBrain Injuries, Traumatic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A